CNO: EPS guidance rose as sales momentum, agent growth, and Medicare Supplement demand continued
Less than 1 min read
Operating EPS rose 47% YoY and FY guidance increased to $5.05–$5.15. Sales and agent growth continued, while Medicare Supplement demand and investment income supported results; management flagged elevated alternative income as unlikely to persist.
Based on CNO Financial Group, Inc. [CNO] Q3 2026 Audio Transcript — Oct. 30 2026
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
© AI-generated summary is provided by Quartr